Skip to content
PubMed This is a summary of 78 peer-reviewed journal articles Updated
Nephrology · Bardet-Biedl Syndrome Type 9

BBS9-Related Ciliopathy: A Patient Guide

At a Glance

BBS9-related ciliopathy is a rare genetic condition that can affect vision, hunger and weight regulation, and kidney health. Coordinated care with vision rehabilitation, support for appetite and weight, and lifelong kidney monitoring can help protect health and independence.

Bardet-Biedl Syndrome type 9 (BBS9) is a rare genetic condition that belongs to a family of disorders known as ciliopathies. It occurs when a specific part of the body’s cellular machinery—the primary cilium—does not function correctly. Because these tiny, hair-like structures act as sensors on almost every cell in the human body, their malfunction can lead to a wide range of symptoms affecting multiple systems at once [1]. For individuals and families, this diagnosis provides a framework to understand why different symptoms, such as extra fingers or toes at birth, vision changes in childhood, or rapid weight gain, may all be connected to the same underlying cause [2].

While the condition is complex, your or your child’s journey is often defined by a few core areas of health. One of the most significant is the progressive change in vision known as rod-cone dystrophy, where the light-sensing cells in the retina gradually break down [3]. Although this leads to challenges with night blindness and a gradual loss of central vision, the focus of modern care is on early rehabilitation, mobility training, and the use of adaptive technology to ensure individuals can navigate their world with confidence and independence [4].

Another central feature of BBS9 is the development of hyperphagia, a biological drive of intense and insatiable hunger [5]. This is not a matter of willpower or behavior but a signaling issue in the body’s hunger pathways. Understanding this allows families to move away from blame and toward effective management. This includes foundational lifestyle routines and, for eligible patients, targeted medications that may help restore the body’s ability to feel full, though responses to these medications can vary [6].

An important contributor to long-term health and prognosis is the management of the kidneys. Many individuals with BBS9 will experience structural or functional kidney issues that require regular, lifelong monitoring by a specialist [7]. By staying vigilant with routine imaging and lab work, your care team can help protect kidney function and address any changes early [8].

Ultimately, a diagnosis of BBS9 marks the beginning of a coordinated approach to care. While the road ahead involves many specialists and ongoing monitoring, it is also a path toward better understanding your unique needs. With a multidisciplinary team to guide you, the focus remains on supporting development, protecting health, and helping you or your child thrive in every stage of life [9].

Common questions in this guide

What is BBS9-related ciliopathy?
BBS9-related ciliopathy, also called Bardet-Biedl syndrome type 9, is a rare genetic condition involving problems with primary cilia, tiny structures that help cells function. It can affect several parts of the body, including vision, appetite and weight regulation, and the kidneys.
How can BBS9-related ciliopathy affect vision?
It can cause rod-cone dystrophy, which gradually damages light-sensing cells in the retina. This may lead to night blindness and progressive loss of central vision, while low-vision services, mobility training, and adaptive technology can support independence.
Why can people with BBS9 experience intense hunger and weight gain?
Hyperphagia is an intense biological drive to eat caused by problems in hunger signaling, not a lack of willpower. Structured daily routines and, for eligible patients, targeted medicines such as setmelanotide may help, although responses vary.
What kidney monitoring is needed with BBS9-related ciliopathy?
BBS9-related ciliopathy can involve structural or functional kidney problems, so regular, lifelong follow-up with a kidney specialist may be recommended. Imaging and laboratory tests help the care team monitor kidney function and identify changes early.
Which specialists and services may be part of BBS9 care?
Care is usually coordinated across a multidisciplinary team because BBS9 can affect several body systems. Depending on individual needs, support may include kidney care, vision rehabilitation, mobility training, adaptive technology, and guidance for appetite and weight management.
Could setmelanotide help with hunger and weight in BBS9?
Setmelanotide is a targeted medication that may help some eligible patients manage intense hunger and weight. Eligibility, expected benefits, and possible risks should be reviewed with the treating specialist because responses can vary.

Get notified when new evidence is published on BBS9-related ciliopathy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Streamlining Diagnosis of Bardet-Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria.

    Pomeroy JJ, Richards J, Sweeney BR, et al.

    American journal of medical genetics. Part A 2026; (200(10)):2181-2198 doi:10.1002/ajmg.a.70199.

    PMID: 42175648
  2. 2

    Collaborative effort: managing Bardet-Biedl syndrome in pediatric patients. Case series and a literature review.

    Nowak-Ciołek M, Ciołek M, Tomaszewska A, et al.

    Frontiers in endocrinology 2024; (15()):1424819 doi:10.3389/fendo.2024.1424819.

    PMID: 39092285
  3. 3

    Autosomal Recessive Rod-Cone Dystrophy with Mild Extra-Ocular Manifestations Due to a Splice-Affecting Variant in BBS9.

    Deitch I, Itskov S, Panneman D, et al.

    Current issues in molecular biology 2024; (46(3)):2566-2575 doi:10.3390/cimb46030163.

    PMID: 38534779
  4. 4

    Ophthalmologic Manifestations in Bardet-Biedl Syndrome: Emerging Therapeutic Approaches.

    Rosado A, Rodriguez E, Izquierdo N

    Medicina (Kaunas, Lithuania) 2025; (61(7)) doi:10.3390/medicina61071135.

    PMID: 40731764
  5. 5

    Hyperphagia in Bardet-Biedl syndrome: Pathophysiology, burden, and management.

    Beales PL, Cetiner M, Haqq AM, et al.

    Obesity reviews : an official journal of the International Association for the Study of Obesity 2025; (26(7)):e13915 doi:10.1111/obr.13915.

    PMID: 40186386
  6. 6

    Setmelanotide in Bardet-Biedl Syndrome: A 52-Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort.

    Argente J, Haqq AM, Schorfheide JL, et al.

    Obesity (Silver Spring, Md.) 2026; (34(3)):579-587 doi:10.1002/oby.70125.

    PMID: 41703984
  7. 7

    Risk Factors for Severe Renal Disease in Bardet-Biedl Syndrome.

    Forsythe E, Sparks K, Best S, et al.

    Journal of the American Society of Nephrology : JASN 2017; (28(3)):963-970 doi:10.1681/ASN.2015091029.

    PMID: 27659767
  8. 8

    Bardet-Biedl syndrome improved diagnosis criteria and management: Inter European Reference Networks consensus statement and recommendations.

    Dollfus H, Lilien MR, Maffei P, et al.

    European journal of human genetics : EJHG 2024; (32(11)):1347-1360 doi:10.1038/s41431-024-01634-7.

    PMID: 39085583
  9. 9

    [The Bardet-Biedl Syndrome - Diagnosis and Follow-up].

    Rohrschneider K, Bolz HJ

    Klinische Monatsblatter fur Augenheilkunde 2020; (237(3)):239-247 doi:10.1055/a-1118-3748.

    PMID: 32182628

This page is for informational purposes and does not replace professional medical advice. Your multidisciplinary care team should interpret your or your child’s symptoms and plan monitoring and treatment.